Kynam Capital Management, LP Amarin Corp Plcuk Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Kynam Capital Management, LP holds 12,155,830 shares of AMRN stock, worth $7.29 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
12,155,830
Previous 12,022,957
1.11%
Holding current value
$7.29 Million
Previous $10.7 Million
21.62%
% of portfolio
0.65%
Previous 1.12%
Shares
8 transactions
Others Institutions Holding AMRN
# of Institutions
187Shares Held
77.1MCall Options Held
247KPut Options Held
121K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$14.9 Million2.89% of portfolio
-
Dg Capital Management, LLC New York, NY5.12MShares$3.07 Million1.36% of portfolio
-
Eversept Partners, LP New York, NY4.31MShares$2.59 Million0.22% of portfolio
-
Two Sigma Investments, LP New York, NY3.04MShares$1.82 Million0.01% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny2.59MShares$1.55 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $242M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...